New Lung Cancer Treatment
A new treatment for lung cancer patients will be available for use in the NHS in England.
Some lung cancer patients, who have had previous chemotherapy treatment, can now be prescribed the new drug Nintedanib, in combination with a chemotherapy drug, called Docetaxel.
However, this combination of drugs is not suitable for all lung cancer patients and is available only for fitter patients.
Dr Jesme Fox, medical director of Roy Castle Lung Cancer Foundation, said: “'We are pleased that NICE has announced that Nintedanib, is to be recommended for use in the NHS in England.“This new therapy is indicated for use in second line treatment, in combination with Docetaxel, in a small selected group of lung cancer patients.
“For many patients, lung cancer remains a devastating disease, with relatively few licenced treatment options. We therefore welcome this announcement."